rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
23
|
pubmed:dateCreated |
2003-10-30
|
pubmed:abstractText |
(E)-3-(Benzenesulfonyl)-2-(methylsulfanyl)pyrido[1,2-a]pyrimidin-4-ylidenamine (7) was found to be a potent and selective 5-HT(6) antagonist. A one-step synthesis of this compound is described.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-2623
|
pubmed:author |
pubmed-author:BertekapRobert LRL,
pubmed-author:Grant-YoungKatharineK,
pubmed-author:HeHuanH,
pubmed-author:HuShuanghuaS,
pubmed-author:HuangYazhongY,
pubmed-author:HugWW,
pubmed-author:KlakouskiCherylC,
pubmed-author:LiYiY,
pubmed-author:ScolaPaul MPM,
pubmed-author:WestphalRyan SRS,
pubmed-author:WuDedongD,
pubmed-author:WuYong-JinYJ
|
pubmed:issnType |
Print
|
pubmed:day |
6
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4834-7
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:14584934-Acrylonitrile,
pubmed-meshheading:14584934-Calcium,
pubmed-meshheading:14584934-Cell Line,
pubmed-meshheading:14584934-Crystallography, X-Ray,
pubmed-meshheading:14584934-Cytochrome P-450 Enzyme System,
pubmed-meshheading:14584934-Humans,
pubmed-meshheading:14584934-Models, Molecular,
pubmed-meshheading:14584934-Pyrimidines,
pubmed-meshheading:14584934-Receptors, Serotonin,
pubmed-meshheading:14584934-Serotonin Antagonists,
pubmed-meshheading:14584934-Structure-Activity Relationship,
pubmed-meshheading:14584934-Sulfones
|
pubmed:year |
2003
|
pubmed:articleTitle |
Identification of a potent and selective 5-HT(6) antagonist: one-step synthesis of (E)-3-(benzenesulfonyl)-2- (methylsulfanyl)pyrido[1,2-a]pyrimidin-4-ylidenamine from 2-(benzenesulfonyl)-3,3-bis(methylsulfanyl)acrylonitrile.
|
pubmed:affiliation |
Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Parkway, Wallingford, Connecticut 06492, USA. yong-jin.wu@bms.com
|
pubmed:publicationType |
Journal Article
|